Hypoglycemia in the treatment of hyperkalemia with insulin in patients with end-stage renal disease
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Hypoglycemia is common in patients with end-stage renal disease (ESRD). We identified the incidence and timing of hypoglycemia and its risk factors in hospitalized patients with ESRD after the treatment of hyperkalemia with insulin. METHODS: We conducted a retrospective study of all hospitalized adult patients treated with hemodialysis who received intravenous insulin to treat hyperkalemia between 1 January 2011 and 31 December 2011. We identified patients who became hypoglycemic [blood glucose <3.3 mmol/L (60 mg/dL)] after insulin administration. RESULTS: Two hundred and twenty-one episodes of hyperkalemia were treated with insulin, resulting in 29 episodes of hypoglycemia (13%). Factors associated with a higher risk of hypoglycemia included no prior diagnosis of diabetes [odds ratio (OR) 2.3, 95% confidence interval (CI) 1.0-5.1, P = 0.05], no use of diabetes medication prior to admission [OR 3.6, 95% CI 1.2-10.7, P = 0.02] and a lower pretreatment glucose level [mean 5.8 ± 0.7 mmol/L (104 ± 12 mg/dL) versus 9.0 ± 0.6 mmol/L (162 ± 11 mg/dL), P = 0.04]. Hypoglycemia occurred at a median of 2 h after insulin administration and persisted for a median of 2 h. CONCLUSIONS: The treatment of hyperkalemia with insulin in hospitalized patients with ESRD may be complicated by hypoglycemia. Patients with a history of diabetes are less susceptible to this complication. Our study supports the use of a protocol to provide dextrose support and blood glucose monitoring for at least 3 h after insulin treatment of hyperkalemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Hypoglycemia is associated with adverse CV outcomes such as prolonged QT intervals, ischemic electrocardiogram changes, angina, arrhythmias, and death.1365”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1365]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
(2005) · Circulation · doi:10.1161/circulationaha.105.166550 · Cited by 1,000
Gerich, J. E., Meyer, C., Woerle, H. J., & Stumvoll, M. (2001) · Diabetes Care · doi:10.2337/diacare.24.2.382 · Cited by 606
Hypoglycemia in Hospitalized Patients
Fischer, K. F., Lees, J. A., & Newman, J. H. (1986) · New England Journal of Medicine · doi:10.1056/nejm198611133152002 · Cited by 309
Parham, W. A., MEHDIRAD, A. A., BIERMANN, K. M., & FREDMAN, C. S. (2006) · Europe PMC (PubMed Central) · Cited by 286
Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients
Allon, M., & Copkney, C. (1990) · Kidney International · doi:10.1038/ki.1990.284 · Cited by 220
Hyperkalemia in end-stage renal disease: mechanisms and management.
Allon, M. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v641134 · Cited by 131
Renal substrate metabolism and gluconeogenesis during hypoglycemia in humans.
Cersosimo, E., Garlick, P., & Ferretti, J. (2000) · Diabetes · doi:10.2337/diabetes.49.7.1186 · Cited by 93
Overview of counterregulation and its abnormalities in diabetes mellitus and other conditions
Gerich, J. E., & Campbell, P. J. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040202 · Cited by 74
Incidence of hypoglycemia following insulin-based acute stabilization of hyperkalemia treatment
Schafers, S., Naunheim, R., Vijayan, A., & Tobin, G. (2012) · Journal of Hospital Medicine · doi:10.1002/jhm.977 · Cited by 70 · cited 1×
“[12] examined the incidence of hypoglycemia after treatment of hyperkalemia with insulin in hospitalized adults.”
Background
Cited by
European Resuscitation Council Guidelines for Resuscitation 2015
Perkins, G. D., Handley, A. J., Koster, R. W., Castrén, M., Smyth, M. A., Olasveengen, T., Monsieurs, K. G., Raffay, V., Gräsner, J.-T., Wenzel, V., et al. (2015) · Resuscitation · doi:10.1016/j.resuscitation.2015.07.015 · Cited by 1,287
European Resuscitation Council Guidelines for Resuscitation 2015
Truhlář, A., Deakin, C. D., Soar, J., Khalifa, G. E. A., Alfonzo, A., Bierens, J. J. L. M., Brattebø, G., Brugger, H., Dunning, J., Hunyadi-Antičević, S., et al. (2015) · Resuscitation · doi:10.1016/j.resuscitation.2015.07.017 · Cited by 819
European Resuscitation Council Guidelines 2021: Cardiac arrest in special circumstances
Lott, C., Truhlář, A., Alfonzo, A., Barelli, A., González-Salvado, V., Hinkelbein, J., Nolan, J. P., Paal, P., Perkins, G. D., Thies, K.-C., et al. (2021) · Resuscitation · doi:10.1016/j.resuscitation.2021.02.011 · Cited by 789
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
European Resuscitation Council Guidelines 2025 Special Circumstances in Resuscitation
Lott, C., Karageorgos, V., Abelairas‐Gómez, C., Alfonzo, A. V. M., Bierens, J. J. L. M., Cantellow, S., Debaty, G. P., Einav, S., Fischer, M. J., Salvado, V. G., et al. (2025) · Resuscitation · doi:10.1016/j.resuscitation.2025.110753 · Cited by 160
Controversies in Management of Hyperkalemia
Long, B., Warix, J. R., & Koyfman, A. (2018) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2018.04.004 · Cited by 143
Truhlář, A., Deakin, C. D., Soar, J., Khalifa, G. E. A., Alfonzo, A. V. M., Bierens, J. J. L. M., Brattebø, G., Brugger, H., Dunning, J., Hunyadi-Antičević, S., et al. (2015) · Notfall + Rettungsmedizin · doi:10.1007/s10049-015-0096-7 · Cited by 63
Potassium homeostasis – Physiology and pharmacology in a clinical context
Kettritz, R., & Loffing, J. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108489 · Cited by 50
Hyperkalemia: Prevalence, Predictors and Emerging Treatments
Larivée, N., Michaud, J. B., More, K. M., Wilson, J.-A. S., & Tennankore, K. (2022) · Cardiology and Therapy · doi:10.1007/s40119-022-00289-z · Cited by 60
Management of Hyperkalemia With Insulin and Glucose: Pearls for the Emergency Clinician
Moussavi, K., Fitter, S., Gabrielson, S. W., Koyfman, A., & Long, B. (2019) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2019.03.043 · Cited by 59
Kreislaufstillstand unter besonderen Umständen: Leitlinien des European Resuscitation Council 2021
Lott, C., Truhlář, A., Alfonzo, A., Barelli, A., Salvado, V. G., Hinkelbein, J., Nolan, J. P., Paal, P., Perkins, G. D., Thies, K., et al. (2021) · Notfall + Rettungsmedizin · doi:10.1007/s10049-021-00891-z · Cited by 59
A Comparison of Insulin Doses for the Treatment of Hyperkalemia in Patients with Renal Insufficiency
LaRue, H., Peksa, G. D., & Shah, S. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2038 · Cited by 54
Correction of Electrolyte Abnormalities in Critically Ill Patients
Bulloch, M. N., Cardinale-King, M., Cogle, S. V., Radparvar, S., Effendi, M. K., Jagpal, S. K., & Dixit, D. (2024) · Intensive Care Research · doi:10.1007/s44231-023-00054-3 · Cited by 54
McNicholas, B., Pham, M. H., Carli, K., Chen, C. H., Smith, N. C., Anderson, A. E., & Pham, H. (2017) · Kidney International Reports · doi:10.1016/j.ekir.2017.10.009 · Cited by 50
Pierce, D. A., Russell, G., & Pirkle, J. L. (2015) · Annals of Pharmacotherapy · doi:10.1177/1060028015607559 · Cited by 48
“These rates, however, were roughly twice the rate of hypoglycemia and 3 to 4 times the rate of severe hypoglycemia found by Schafers and colleagues18 and higher than those found by Apel et al.19 Among those with low eGFR (ESRD) given 10 units, the rate was much higher than that found by Apel et al19 (31% vs 13%).”
BackgroundResultInfluentialEvaluation and management of diabetic and non-diabetic hypoglycemia in end-stage renal disease
Gosmanov, A. R., Gosmanova, E. O., & Kovesdy, C. P. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv258 · Cited by 48
Insulin for the treatment of hyperkalemia: a double-edged sword?
Li, T., & Vijayan, A. (2014) · Clinical Kidney Journal · doi:10.1093/ckj/sfu049 · Cited by 46
Management of diabetes mellitus in chronic kidney disease
Garla, V. V., Kanduri, S. R., Yanes-Cardozo, L. L., & Lien, L. F. (2019) · Minerva Endocrinology · doi:10.23736/s0391-1977.19.03015-3 · Cited by 46
Weight‐based insulin dosing for acute hyperkalemia results in less hypoglycemia
Wheeler, D. T., Schafers, S. J., Horwedel, T. A., Deal, E. N., & Tobin, G. S. (2016) · Journal of Hospital Medicine · doi:10.1002/jhm.2545 · Cited by 45
Coca, A., Valencia, A. L., Bustamante, J., Mendiluce, A., & Floege, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172961 · Cited by 42
Scott, N. L., Klein, L. R., Cales, E. K., & Driver, B. E. (2018) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2018.05.016 · Cited by 39
Reduced Versus Conventional Dose Insulin for Hyperkalemia Treatment
Garcia, J. A., Pintens, M., Morris, A. A., Takamoto, P., Baumgartner, L. J., & Tasaka, C. L. (2018) · Journal of Pharmacy Practice · doi:10.1177/0897190018799220 · Cited by 34
Impact of dextrose dose on hypoglycemia development following treatment of hyperkalemia
Farina, N., & Anderson, C. (2018) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098618768725 · Cited by 30
Iatrogenic hypoglycaemia following glucose‐insulin infusions for the treatment of hyperkalaemia
Tee, S. A., Devine, K., Potts, A., Javaid, U., Razvi, S., Quinton, R., Roberts, G. A., & Leech, N. (2020) · Clinical Endocrinology · doi:10.1111/cen.14343 · Cited by 29
Preventing Hypoglycemia Following Treatment of Hyperkalemia in Hospitalized Patients
Boughton, C. K., Dixon, D. J., Goble, E., Burridge, A. M., Cox, A., Noble‐Bell, G., Bell, C., Fidler, B., Chudley, J., Anderson, C. E., et al. (2019) · Journal of Hospital Medicine · doi:10.12788/jhm.3145 · Cited by 28
A randomized study to compare oral potassium binders in the treatment of acute hyperkalemia
Cañas, A. E., Troutt, H. R., Jiang, L., Tonthat, S., Darwish, O. S., Ferrey, A., Lotfipour, S., Kalantar‐Zadeh, K., Hanna, R. M., & Lau, W. L. (2023) · BMC Nephrology · doi:10.1186/s12882-023-03145-x · Cited by 27
The Association of Insulin-dextrose Treatment with Hypoglycemia in Patients with Hyperkalemia
Crnobrnja, L., Metlapalli, M., Jiang, C., Govinna, M., & Lim, A. K. H. (2020) · Scientific Reports · doi:10.1038/s41598-020-79180-7 · Cited by 26
Truhlář, A., Deakin, C. D., Soar, J., Khalifa, G. E. A., Alfonzo, A. V. M., Bierens, J. J. L. M., Brattebø, G., Brugger, H., Dunning, J., Hunyadi-Antičević, S., et al. (2017) · Notfall + Rettungsmedizin · doi:10.1007/s10049-017-0337-z · Cited by 26
Evidence in support of hyperkalaemia management strategies: A systematic literature review
Palaka, E., Leonard, S. A., Buchanan-Hughes, A., Bobrowska, A., Langford, B., & Grandy, S. (2018) · International Journal of Clinical Practice · doi:10.1111/ijcp.13052 · Cited by 23
Comparison of IV Insulin Dosing Strategies for Hyperkalemia in the Emergency Department
Moussavi, K., Nguyen, L. T., Hua, H., & Fitter, S. (2020) · Critical Care Explorations · doi:10.1097/cce.0000000000000092 · Cited by 23
Jacob, B. C., Peasah, S. K., Chan, H., Niculas, D., & Nwaesei, A. S. (2018) · Hospital Pharmacy · doi:10.1177/0018578718779012 · Cited by 23
Chothia, M., Humphrey, T. J. L., Schoonees, A., Chikte, U. M. E., & Davids, M. R. (2022) · PLoS ONE · doi:10.1371/journal.pone.0268395 · Cited by 22
Brown, K., Setji, T. L., Hale, S. L., Cooper, A. A., Hong, B. D., Herbst, R., Musser, R. C., Freeman, S., Shaikewitz, T., Greenlee, J., et al. (2018) · American Journal of Medical Quality · doi:10.1177/1062860618764610 · Cited by 20
Decreasing Hypoglycemia following Insulin Administration for Inpatient Hyperkalemia
Tran, A. V., Rushakoff, R. J., Prasad, P. A., Murray, S. G., Monash, B., & MacMaster, H. W. (2020) · Journal of Hospital Medicine · doi:10.12788/jhm.3357 · Cited by 20
Current therapeutic approaches in the management of hyperglycemia in chronic renal disease
Garla, V. V., Yanes-Cardozo, L. L., & Lien, L. F. (2017) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-017-9416-1 · Cited by 19
Incidence and Causes of Iatrogenic Hypoglycemia in the Emergency Department
Chittineni, C., Driver, B. E., Halverson, M., Cole, J. B., Prekker, M. E., Pandey, V., Lai, T., Harrington, J., Zhao, S. Z., & Klein, L. R. (2019) · Western Journal of Emergency Medicine · doi:10.5811/westjem.2019.7.42996 · Cited by 16
Emektar, E. (2023) · Turkish Journal of Emergency Medicine · doi:10.4103/tjem.tjem_288_22 · Cited by 12
Blood glucose reduction in patients treated with insulin and dextrose for hyperkalaemia
Aljabri, A. M., Perona, S. J., Alshibani, M., Khobrani, M. A., Jarrell, D. H., & Patanwala, A. E. (2019) · Emergency Medicine Journal · doi:10.1136/emermed-2019-208744 · Cited by 12
Long, D. S., Kelly, M., & Lim, S. H. (2022) · International Journal of Nursing Practice · doi:10.1111/ijn.13080 · Cited by 10
Yang, I., Smalley, S., Ahuja, T., Merchan, C., Smith, S. W., & Papadopoulos, J. (2019) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2019.09.003 · Cited by 9
Predicting hypoglycemia after treatment of hyperkalemia with insulin and glucose (Glu-K60 score)
Kijprasert, W., Tarudeeyathaworn, N., Loketkrawee, C., Pimpaporn, T., Pattarasettaseranee, P., & Tangsuwanaruk, T. (2022) · BMC Emergency Medicine · doi:10.1186/s12873-022-00748-9 · Cited by 8
Verdier, M., DeMott, J. M., & Peksa, G. D. (2021) · Australian Critical Care · doi:10.1016/j.aucc.2021.05.004 · Cited by 8
Dybdahl, D., Roberson, T., Rasor, E., Kline, L., & Pershing, M. L. (2023) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2023.12.001 · Cited by 6
ERRATUM: Decreasing Hypoglycemia following Insulin Administration for Inpatient Hyperkalemia
Tran, A. V., Rushakoff, R. J., Prasad, P. A., Murray, S. G., Monash, B., & MacMaster, H. W. (2020) · Journal of Hospital Medicine · doi:10.12788/jhm.3413 · Cited by 6
Yunita, E. P., Asriyanti, N. L. P. G., & Gunawan, A. (2022) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2022.00002 · Cited by 5
Lim, S. H., Wahab, S. N. B. A., Ang, S. Y., Teh, M. M., & Aloweni, F. B. A. B. (2022) · Journal of Emergency Nursing · doi:10.1016/j.jen.2022.09.009 · Cited by 5
2025 Korean Guidelines for Cardiopulmonary Resuscitation: Part 4. Adult advanced life support
Kim, T.-Y., Ahn, G. J., Cha, K., Kim, D., Sohn, Y. D., Song, Y. R., Shim, G. H., Kim, D. K., Oh, Y., Wi, J. H., et al. (2026) · Clinical and Experimental Emergency Medicine · doi:10.15441/ceem.26.073 · Cited by 3
Reducing the harm associated in treating hyperkalaemia with insulin and dextrose
Sherif, S. A., Katsaiti, I., Jebb, H., Banh, S., Bedi, R., Levy, J. B., Thomas, D., Ashby, D. R., & Corbett, R. (2024) · Clinical Medicine · doi:10.1016/j.clinme.2024.100222 · Cited by 3
Chaurasia, V., Jamshed, N., Aggrawal, P., Bhoi, S., Ekka, M., Sinha, T. P., Kumar, A., Mishra, P. R., & Das, A. K. (2024) · Acute and Critical Care · doi:10.4266/acc.2024.00661 · Cited by 3
Chothia, M., Chikte, U. M. E., & Davids, M. R. (2022) · African Journal of Nephrology · doi:10.21804/25-1-5002 · Cited by 3
Acute Hyperkalemia Management in the Emergency Department
Weant, K. A., & Gregory, H. (2024) · Advanced Emergency Nursing Journal · doi:10.1097/tme.0000000000000504 · Cited by 3
Mallappallil, M. C., Sasidharan, S., Sabu, J., & John, S. (2024) · Cureus · doi:10.7759/cureus.64663 · Cited by 3
Ibarra, F., Fountain, C., & Fallert, T. (2024) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2024.07.061 · Cited by 3
Brown, D. R., Brown, C. C., Delay, T. A., Hayes, G. L., & Campbell, R. C. (2019) · International Archives of Clinical Pharmacology · doi:10.23937/2572-3987.1510018 · Cited by 3
Frequency of serum blood glucose monitoring after hyperkalaemia treatment using insulin and dextrose
Aljabri, A. M., & Alsulami, S. (2021) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2021.07.014 · Cited by 3
Inpatient Management of Patients with Diabetes and Kidney Disease
Patel, E., Kim, S. H., & Gianchandani, R. Y. (2023) · Contemporary Endocrinology · doi:10.1007/978-3-031-44648-1_23 · Cited by 2
Hyperkalemia Management with Intravenous Insulin in Patients with Reduced Kidney Function
Alzahrani, M. A., Alabdan, N., Alahmari, Z. S., Alshehri, N., Alotaibi, L. H., & Almohammed, O. A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13175103 · Cited by 2
Al‐Sharefi, A., Quinton, R., & Roberts, G. A. (2019) · Journal of Hospital Medicine · doi:10.12788/jhm.3209 · Cited by 2
Risks of Hypoglycemia with Insulin Therapy for Hyperkalemia
Long, B., Warix, J. R., & Koyfman, A. (2019) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2018.12.030 · Cited by 2
Kroll, C., Khan, M., Sun, J., Vakkalanka, J. P., Lee, K., Said, M., & Halfpap, J. (2025) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2025.12.031 · Cited by 1
Diagnosis and management of acute hyperkalaemia
Rech, M. A., Zimmerman, D. E., Ray, L. C., Desai, D., Hoffman, J. W., & Howington, G. T. (2026) · BMJ · doi:10.1136/bmj-2026-100287 · Cited by 1
Lui, V. H. Y. (2019) · ScholarSpace (University of Hawaii at Manoa) · Cited by 1
Insulin: Hypoglycaemia: case report
(2014) · Reactions Weekly · doi:10.1007/s40278-014-1855-9
Öberg, C. M., Sternby, J., Nilsson, A., Storr, M., Flieg, R., Harenski, K., Roos, V., Källquist, L., & Hobro, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-46715-7
Lim, S. H., Ang, S. Y., Wahab, S. N. B. A., Teh, M. M., & Aloweni, F. B. A. B. (2025) · Proceedings of Singapore Healthcare · doi:10.1177/20101058251335693
Kotian, A., Cain, K. E., Moser, T., Patel, R. P., Warren, M. L., & Thosani, S. (2025) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552251356915
Cañas, A. E., Troutt, H. R., Jiang, L., Tonthat, S., Darwish, O. S., Ferrey, A., Lotfipour, S., Kalantar‐Zadeh, K., Hanna, R., & Lau, W. L. (2023) · Figshare · doi:10.6084/m9.figshare.22620307
Evaluation of Intravenous Insulin Lispro for Hyperkalemia Treatment in Emergency Department Patients
Khan, M., Lee, K., Halfpap, J., & Kroll, C. (2026) · Journal of Acute Care Pharmacotherapy · doi:10.67122/001c.156010
Metadata
- Authors
- Apel, J., Reutrakul, S., & Baldwin, D.
- Affiliations
- Rush University Medical Center (US)
- Mahidol University (TH)
- Corresponding author
- Apel, J.
- ORCID
- Reutrakul, S.
- Venue
- Clinical Kidney Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-03-18
- Volume
- 7
- Issue
- 3
- Pages
- 248-250
- ISSN
- 2048-8505 (ISSN-L)
- 2048-8513
- PMC
- PMC4377748
- OpenAlex
- W2150100479
- Cited by
- 67
- References
- 16
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 7 · 2023: 7 · 2022: 8 · 2021: 4 · 2020: 5 · 2019: 9 · 2018: 7 · 2017: 5 · 2016: 1 · 2015: 5 · 2014: 2
- FWCI
- 3.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Clinical Kidney Journal (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Potassium and Related Disorders
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- hypoglycemia, hyperkalemia, insulin therapy, end-stage renal disease, hemodialysis, diabetes mellitus, risk factors, dextrose supplementation, blood glucose monitoring, hospitalized patients
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.